Abstract:Background. Hepatocellular carcinoma (HCC) is one of the most common malignancies, and although there are several treatment options, the overall results are not satisfactory. Cancer-associated fibroblasts (CAFs) can promote cancer progression through various mechanisms. Methods. HCC-associated mRNA data were sourced from The Cancer Genome Atlas database (TCGA) and International Cancer Genome Consortium (ICGC) database. First, the differentially expressed CAF-related genes (CAF-DEGs) were acquired by difference analysis and weighted gene coexpression network analysis (WGCNA). Moreover, a CAF-related risk model was built by Cox analysis. Kaplan-Meier (K-M) curves and receiver operating characteristic (ROC) curves were utilized to evaluate the validity of this risk model. Furthermore, enrichment analysis of differentially expressed genes (DEGs) between the high- and low-risk groups was executed to explore the functions relevant to the risk model. Furthermore, this study compared the differences in immune infiltration, immunotherapy, and drug sensitivity between the high- and low-risk groups. Finally, we verified the mRNA expression levels of selected prognostic genes by quantitative real-time polymerase chain reaction (qRT-PCR). Results. 107 CAF-DEGs were identified in the HCC samples, and five prognosis-related genes (ACTA2, IGJ, CTHRC1, CXCL12, and LAMB1) were obtained by Cox analysis and utilized to build a CAF-related risk model. K-M analysis illustrated a low survival in the high-risk group, and ROC curves revealed that the risk model could accurately predict the 1-, 3-, and 5-year overall survival (OS) of HCC patients. In addition, Cox analysis demonstrated that the risk score was an independent prognostic factor. Enrichment analysis illustrated that DEGs between the high- and low-risk groups were related to immune response, amino acid metabolism, and fatty acid metabolism. Furthermore, risk scores were correlated with the tumor microenvironment, CAF scores, and TIDE scores, and CAF-related marker genes were positively correlated with all five model genes. Notably, the risk model was relevant to the sensitivity of chemotherapy drugs. Finally, the results of qRT-PCR demonstrated that the expression levels of 5 model genes were in accordance with the analysis. Conclusion. A CAF-related risk model based on ACTA2, IGJ, CTHRC1, CXCL12, and LAMB1 was built and could be utilized to predict the prognosis and treatment of HCC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the prognostic evaluation and treatment effect prediction of hepatocellular carcinoma (HCC). Specifically, the researchers focused on the role of cancer - associated fibroblasts (CAFs) in the progression of HCC and attempted to construct a risk model by identifying gene signatures associated with CAFs to predict patient survival rates and responses to treatment. This helps to improve the effectiveness of clinical diagnosis and treatment strategies for HCC. ### Background Hepatocellular carcinoma (HCC) is a common malignant tumor. Although there are multiple treatment methods, the overall efficacy is not satisfactory. Cancer - associated fibroblasts (CAFs) promote cancer development through multiple mechanisms. Therefore, studying the role of CAFs in HCC and their associated gene signatures is of great significance for improving the prognosis of HCC. ### Methods 1. **Data sources**: Obtain HCC - related mRNA data from the TCGA database and the ICGC database. 2. **Differential expression gene analysis**: Obtain cancer - associated fibroblast - related differentially expressed genes (CAF - DEGs) through differential analysis and weighted gene co - expression network analysis (WGCNA). 3. **Risk model construction**: Use Cox regression analysis to construct a CAF - related risk model. 4. **Model validation**: Use Kaplan - Meier curves and receiver operating characteristic curves (ROC curves) to evaluate the effectiveness of the risk model. 5. **Functional enrichment analysis**: Compare the differentially expressed genes between the high - risk group and the low - risk group and perform functional enrichment analysis. 6. **Immune infiltration and drug sensitivity analysis**: Compare the differences in immune infiltration, immunotherapy, and drug sensitivity between the high - risk group and the low - risk group. 7. **Experimental verification**: Verify the mRNA expression levels of selected prognostic genes by quantitative real - time polymerase chain reaction (qRT - PCR). ### Results 1. **Identification of CAF - DEGs**: 107 CAF - DEGs were identified in HCC samples. 2. **Construction of risk model**: Five prognosis - related genes (ACTA2, IGJ, CTHRC1, CXCL12, and LAMB1) were obtained through Cox regression analysis and used to construct a CAF - related risk model. 3. **Survival analysis**: K - M analysis showed that the survival rate in the high - risk group was lower, and the ROC curve indicated that the risk model could accurately predict the 1 - year, 3 - year, and 5 - year overall survival rates (OS) of HCC patients. 4. **Independent prognostic factor**: Cox regression analysis showed that the risk score was an independent prognostic factor. 5. **Functional enrichment analysis**: The differentially expressed genes were mainly related to immune responses, amino acid metabolism, and fatty acid metabolism. 6. **Immune infiltration and drug sensitivity**: The risk score was related to the tumor microenvironment, CAF score, and TIDE score, and the CAF - related marker genes were positively correlated with the five genes in the model. 7. **Drug sensitivity**: The risk model was related to the sensitivity of chemotherapeutic drugs. 8. **Experimental verification**: The qRT - PCR results confirmed that the expression levels of the five model genes were consistent with the analysis results. ### Conclusion The CAF - related risk model constructed based on ACTA2, IGJ, CTHRC1, CXCL12, and LAMB1 can be used to predict the prognosis and treatment effect of HCC, providing a reference for clinical applications.

Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis

Development of a Cancer-associated Fibroblast Signature for Evaluating Immunotherapy Response and Prognosis of Hepatocellular Carcinoma

Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes.

Prognostic Prediction and Immunotherapy Response Analysis of the Fatty Acid Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma

Single-cell transcriptome analysis reveals a cancer-associated fibroblast marker gene signature in hepatocellular carcinoma that predicts prognosis

A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma

A Novel Prognostic Model for Identifying the Risk of Hepatocellular Carcinoma Based on Angiogenesis Factors

Establishment and verification of a prognostic model based on coagulation and fibrinolysis-related genes in hepatocellular carcinoma

Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma

Establishment of Prognosis Model of Hepatocellular Carcinoma Based on Prognosis Related Gene Analysis and Study on Gene Regulation Mechanism of Model

Construction a Six-Gene Prognostic Model for Hepatocellular Carcinoma Based on WGCNA Co-Expression Network

Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients

Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma

The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma

Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach

Integrative study reveals the prognostic and immunotherapeutic value of CTCs/CTMs -related prognostic signature in Hepatocellular carcinoma

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma

A Four-Gene-based Prognostic Model Predicts Overall Survival in Patients with Hepatocellular Carcinoma